Vasoactive enzymes and blood flow responses to passive and active exercise in peripheral arterial disease
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Vasoactive enzymes and blood flow responses to passive and active exercise in peripheral arterial disease. / Walker, Meegan A.; Høier, Birgitte; Walker, Philip J.; Schulze, Karl; Bangsbo, Jens; Hellsten, Ylva; Askew, Christopher D.
I: Atherosclerosis, Bind 246, 2016, s. 98-105.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Vasoactive enzymes and blood flow responses to passive and active exercise in peripheral arterial disease
AU - Walker, Meegan A.
AU - Høier, Birgitte
AU - Walker, Philip J.
AU - Schulze, Karl
AU - Bangsbo, Jens
AU - Hellsten, Ylva
AU - Askew, Christopher D.
N1 - CURIS 2016 NEXS 026
PY - 2016
Y1 - 2016
N2 - Background: Peripheral arterial disease (PAD) is characterised by impaired leg blood flow, which contributes to claudication and reduced exercise capacity. This study investigated to what extent vasoactive enzymes might contribute to altered blood flow in PAD (Fontaine stage II). Methods: We compared femoral artery blood flow during reactive hyperaemia, leg-extension exercise and passive leg movement, and determined the level of vasoactive enzymes in skeletal muscle samples from the vastus lateralis in PAD (n = 10, 68.5 ± 6.5 years) and healthy controls (CON, n = 9, 62.1 ± 12.3 years). Leg blood flow was measured with Doppler ultrasound and muscle protein levels of phosphorylated endothelial nitric oxide synthase, NADPH oxidase, cyclooxygenase 1 and 2, thromboxane synthase, and prostacyclin synthase were determined. Results: Leg blood flow during the initial 90 s of passive leg movement (242 ± 33 vs 441 ± 75 ml min-1, P = 0.03) and during reactive hyperaemia (423 ± 100 vs 1255 ± 175 ml min-1, P = 0.002) was lower in PAD than CON, whereas no significant difference was observed for leg blood flow during exercise (1490 ± 250 vs 1887 ± 349 ml min-1, P = 0.37). PAD had higher NADPH oxidase than CON (1.04 ± 0.19 vs 0.50 ± 0.06 AU, P = 0.02), with no differences for other enzymes. Leg blood flow during exercise was correlated with prostacyclin synthase (P = 0.001). Conclusion: Elevated NADPH oxidase indicates that oxidative stress may be a primary cause of low nitric oxide availability and impaired blood flow in PAD.
AB - Background: Peripheral arterial disease (PAD) is characterised by impaired leg blood flow, which contributes to claudication and reduced exercise capacity. This study investigated to what extent vasoactive enzymes might contribute to altered blood flow in PAD (Fontaine stage II). Methods: We compared femoral artery blood flow during reactive hyperaemia, leg-extension exercise and passive leg movement, and determined the level of vasoactive enzymes in skeletal muscle samples from the vastus lateralis in PAD (n = 10, 68.5 ± 6.5 years) and healthy controls (CON, n = 9, 62.1 ± 12.3 years). Leg blood flow was measured with Doppler ultrasound and muscle protein levels of phosphorylated endothelial nitric oxide synthase, NADPH oxidase, cyclooxygenase 1 and 2, thromboxane synthase, and prostacyclin synthase were determined. Results: Leg blood flow during the initial 90 s of passive leg movement (242 ± 33 vs 441 ± 75 ml min-1, P = 0.03) and during reactive hyperaemia (423 ± 100 vs 1255 ± 175 ml min-1, P = 0.002) was lower in PAD than CON, whereas no significant difference was observed for leg blood flow during exercise (1490 ± 250 vs 1887 ± 349 ml min-1, P = 0.37). PAD had higher NADPH oxidase than CON (1.04 ± 0.19 vs 0.50 ± 0.06 AU, P = 0.02), with no differences for other enzymes. Leg blood flow during exercise was correlated with prostacyclin synthase (P = 0.001). Conclusion: Elevated NADPH oxidase indicates that oxidative stress may be a primary cause of low nitric oxide availability and impaired blood flow in PAD.
KW - Leg blood flow
KW - NADPH oxidase
KW - Peripheral arterial disease
KW - Vasoactive enzymes
U2 - 10.1016/j.atherosclerosis.2015.12.029
DO - 10.1016/j.atherosclerosis.2015.12.029
M3 - Journal article
C2 - 26771386
AN - SCOPUS:84953246862
VL - 246
SP - 98
EP - 105
JO - Atherosclerosis
JF - Atherosclerosis
SN - 0021-9150
ER -
ID: 153442840